Another Round of Coronavirus Cases Puts This Biotech ETF in Focus

Already one of the ETFs at the center of the coronavirus investment thesis, the ALPS Medical Breakthroughs ETF (SBIO) could be poised for more upside as the U.S. grapples with a second wave of the respiratory illness. SBIO focuses on small- and mid-cap companies that have one or more drugs in...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.